Back
Day Range
$12.66
$13.49
52-Week Range
$3.91
$19.11
Volume
831,314
50D / 200D Avg
$15.09
/
$13.15
Prev Close
$13.23
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.6 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | -72.2 | 3.7 |
| Net Margin % | -739.4 | 3.9 |
| Rev Growth 5Y % | -4.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$37.50
+192.3%
Low: $36.00
High: $39.00
Forward EPS
-$3.22
Est. Revenue
3.8 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.88
$0.54 – $5.21
|
880 M | 5 |
| FY2029 |
$0.87
$0.17 – $1.58
|
570 M | 2 |
| FY2028 |
-$1.17
-$2.25 – $0.31
|
290 M | 7 |
Key Takeaways
Revenue declined -4.00% annually over 5 years
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -243.39M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23.50%
Growth
Revenue Growth (5Y)
-4.00%
Revenue (1Y)-27.50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-72.19%
ROIC-55.85%
Net Margin-739.42%
Op. Margin-775.98%
Safety
Debt / Equity
0.07
Current Ratio8.88
Interest Coverage7376.79
Valuation
P/E Ratio
-4.61
P/B Ratio3.50
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27.50% | Revenue Growth (3Y) | -17.43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -4.00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 31.37M | Net Income (TTM) | -231.96M |
| ROE | -72.19% | ROA | -63.73% |
| Gross Margin | 93.41% | Operating Margin | -775.98% |
| Net Margin | -739.42% | Free Cash Flow (TTM) | -243.39M |
| ROIC | -55.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 8.88 |
| Interest Coverage | 7376.79 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.61 | P/B Ratio | 3.50 |
| P/S Ratio | 34.12 | PEG Ratio | -0.16 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.07B | Enterprise Value | 989.38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 31.37M | 43.27M | 46.02M | 41.40M | 36.94M |
| Net Income | -231.96M | -130.87M | -70.80M | -102.25M | -58.42M |
| EPS (Diluted) | -3.17 | -2.32 | -1.82 | -2.74 | -2.03 |
| Gross Profit | 29.31M | 39.56M | 41.39M | 33.08M | 28.76M |
| Operating Income | -243.43M | -145.85M | -75.07M | -99.64M | -55.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 364.00M | 418.47M | 355.18M | 180.36M | 263.37M |
| Total Liabilities | 57.88M | 81.96M | 88.86M | 83.99M | 78.99M |
| Shareholders' Equity | 306.11M | 336.50M | 266.32M | 96.37M | 184.38M |
| Total Debt | 20.77M | 21.86M | 4.91M | 46.35M | 39.20M |
| Cash & Equivalents | 101.82M | 99.70M | 281.26M | 95.63M | 178.59M |
| Current Assets | 328.66M | 383.31M | 344.80M | 172.81M | 237.75M |
| Current Liabilities | 37.02M | 49.05M | 63.26M | 34.54M | 23.66M |